Option Care Health (NASDAQ:OPCH) Given New $33.00 Price Target at JPMorgan Chase & Co.

Key Points

• JPMorgan cut its price target on Option Care Health from $40 to $33 while keeping an "overweight" rating, a level that implies roughly a 56% upside from the current share price.
• Option Care traded at $21.14 (market cap ~$3.32B) and reported Q results with EPS $0.40 (beat $0.37) but revenue of $1.35B (missed $1.39B); management set FY2026 guidance of $1.82–$1.92 EPS and the stock's 1‑year range is $18.01–$36.80.

Option Care Health (NASDAQ:OPCH - Get Free Report) had its price target decreased by JPMorgan Chase & Co. from $40.00 to $33.00 in a report issued on Monday,Benzinga reports. The firm currently has an "overweight" rating on the stock. JPMorgan Chase & Co.'s price target would indicate a potential upside of 56.10% from the stock's current price.

A number of other brokerages have also recently weighed in on OPCH. National Bank Financial set a $37.00 price target on shares of Option Care Health in a research note on Tuesday, January 27th. Morgan Stanley raised their target price on shares of Option Care Health from $35.00 to $38.00 and gave the stock an "overweight" rating in a research note on Tuesday, January 13th. Wall Street Zen cut shares of Option Care Health from a "buy" rating to a "hold" rating in a research note on Saturday, February 28th. Barrington Research reduced their target price on shares of Option Care Health from $42.00 to $32.00 and set an "outperform" rating for the company in a research note on Friday. Finally, Jefferies Financial Group restated a "buy" rating and issued a $37.00 target price on shares of Option Care Health in a research note on Tuesday, January 13th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $32.08.

Option Care Health Stock Performance

NASDAQ:OPCH traded up $1.11 during trading hours on Monday, reaching $21.14. 7,188,833 shares of the company's stock were exchanged, compared to its average volume of 2,140,583. The firm has a market capitalization of $3.32 billion, a price-to-earnings ratio of 16.39, a P/E/G ratio of 1.12 and a beta of 0.68. The company has a 50-day moving average of $29.15 and a 200 day moving average of $30.74. The company has a quick ratio of 1.07, a current ratio of 1.64 and a debt-to-equity ratio of 0.85. Option Care Health has a 1-year low of $18.01 and a 1-year high of $36.80.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings results on Thursday, April 30th. The company reported $0.40 earnings per share for the quarter, topping analysts' consensus estimates of $0.37 by $0.03. The firm had revenue of $1.35 billion during the quarter, compared to analysts' expectations of $1.39 billion. Option Care Health had a net margin of 3.64% and a return on equity of 18.17%. Option Care Health's quarterly revenue was up 1.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.40 EPS. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Research analysts anticipate that Option Care Health will post 1.69 EPS for the current year.

Hedge Funds Weigh In On Option Care Health

A number of large investors have recently made changes to their positions in the stock. Durable Capital Partners LP increased its holdings in shares of Option Care Health by 134.2% in the 2nd quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company's stock valued at $267,557,000 after purchasing an additional 4,720,988 shares in the last quarter. Fuller & Thaler Asset Management Inc. increased its holdings in Option Care Health by 12.1% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 6,958,800 shares of the company's stock valued at $221,707,000 after acquiring an additional 752,058 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its holdings in Option Care Health by 6.2% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 4,248,425 shares of the company's stock valued at $135,355,000 after acquiring an additional 247,118 shares in the last quarter. Dimensional Fund Advisors LP raised its position in Option Care Health by 1.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,840,648 shares of the company's stock worth $122,367,000 after acquiring an additional 44,252 shares during the last quarter. Finally, Morgan Stanley lifted its holdings in shares of Option Care Health by 13.3% in the fourth quarter. Morgan Stanley now owns 3,410,233 shares of the company's stock valued at $108,650,000 after purchasing an additional 400,740 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company's stock.

About Option Care Health

Option Care Health NASDAQ: OPCH is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry's most experienced home infusion businesses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.